-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 VMQ4mYMu/L/0eBkvO3YOUyx2hUl/Pb7QwS5MSbRnoN1941YbtnLCTnJQhS7qC/jb
 Rblo0y2RqnEqDNzlD0A/tA==

<SEC-DOCUMENT>0001144204-07-045839.txt : 20070822
<SEC-HEADER>0001144204-07-045839.hdr.sgml : 20070822
<ACCEPTANCE-DATETIME>20070822164153
ACCESSION NUMBER:		0001144204-07-045839
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20070821
FILED AS OF DATE:		20070822
DATE AS OF CHANGE:		20070822

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			XTL BIOPHARMACEUTICALS LTD
		CENTRAL INDEX KEY:			0001023549
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000

	BUSINESS ADDRESS:	
		STREET 1:		711 EXECUTIVE BOULEVARD
		STREET 2:		SUITE Q
		CITY:			VALLEY COTTAGE
		STATE:			NY
		ZIP:			10989
		BUSINESS PHONE:		972-8-930-4440

	MAIL ADDRESS:	
		STREET 1:		711 EXECUTIVE BOULEVARD
		STREET 2:		SUITE Q
		CITY:			VALLEY COTTAGE
		STATE:			NY
		ZIP:			10989

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Kessler William
		CENTRAL INDEX KEY:			0001410538

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51310
		FILM NUMBER:		071073398

	BUSINESS ADDRESS:	
		BUSINESS PHONE:		845-267-0707

	MAIL ADDRESS:	
		STREET 1:		C/O XTL BIOPHARMACEUTICALS LTD.
		STREET 2:		711 EXECUTIVE BLVD., SUITE Q
		CITY:			VALLEY COTTAGE
		STATE:			NY
		ZIP:			10989
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>v085974_ex.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2007-08-21</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001023549</issuerCik>
        <issuerName>XTL BIOPHARMACEUTICALS LTD</issuerName>
        <issuerTradingSymbol>XTLB</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001410538</rptOwnerCik>
            <rptOwnerName>Kessler William</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O XTL BIOPHARMACEUTICALS LTD.</rptOwnerStreet1>
            <rptOwnerStreet2>711 EXECUTIVE BLVD., SUITE Q</rptOwnerStreet2>
            <rptOwnerCity>VALLEY COTTAGE</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10989</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>Director of Finance</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>American Depositary Receipts (ADRs) of Common Shares</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>5000</value>
                    <footnoteId id="F1"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">On August 21, 2007, Mr. Kessler purchased 5,000 ADRs at a price of $1.29.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Bill Kessler</signatureName>
        <signatureDate>2007-08-22</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
